BETA-AMYLOID PRECURSOR PROTEIN OF ALZHEIMER-DISEASE OCCURS AS 110-KILODALTON TO 135-KILODALTON MEMBRANE-ASSOCIATED PROTEINS IN NEURAL AND NONNEURAL TISSUES
BETA-AMYLOID PRECURSOR PROTEIN OF ALZHEIMER-DISEASE OCCURS AS 110-KILODALTON TO 135-KILODALTON MEMBRANE-ASSOCIATED PROTEINS IN NEURAL AND NONNEURAL TISSUES
复制标题
DOI:
10.1073/pnas.85.19.7341
复制
发表时间:
1988-10-01
影响因子:
11.1
通讯作者:
OLTERSDORF, T
中科院分区:
文献类型:
--
作者:
SELKOE, DJ;PODLISNY, MB;OLTERSDORF, T
Progressive cerebral deposition of extracellular filaments composed of the .beta.-amyloid protein (.beta.AP) is a constant feature of Alzheimer disease (AD). Since the gene on chromosome 21 encoding the .beta.AP precursor (.beta.APP) is not known to be altered in AD, transcriptional or posttranslational changes may underlie accelerated .beta.AP deposition. Using two antibodies to the predicted carboxyl terminus of .beta.APP, we have identified the native .beta.APP in brain and nonneural human tissues as a 110- to 135-kDa protein complex that is insoluble in buffer and found in various membrane-rich subcellular fractions. These proteins are relatively uniformly distributed in adult brain, abundant in fetal brain, and detected in nonneural tissues that contain .beta.APP mRNA. Similarly sized proteins occur in rat, cow, and monkey brain and in cultured human HL-60 and HeLa cells; the precise patterns in the 110- to 135-kDa range are heterogeneous among various tissues and cell lines. Confirmation that the immunodetected tissue proteins are forms of .beta.APP was obtained when mammalian cells transfected with a full-length .beta.APP cDNA showed selectively augmented expression of 110- to 135-kDa proteins and specific immunocytochemical staining. Unexpectedly, the antibodies to the carboxyl terminus of .beta.APP labeled amyloid-containing senile plaques in AD brain. We conclude that the highly conserved .beta.APP molecule occurs in mammalian tissues as a heterogeneous group of membrane-associated proteins of .apprxeq. 120 kDa. Detection of the nonamyloidogenic carboxyl terminus within plaques suggests that proteolytic processing of the .beta.APP into insoluble filaments occurs locally in cortical regions that develop .beta.-amyloid deposits with age.